Pfizer (United Kingdom)

5.4k papers and 208.0k indexed citations i.

About

In recent decades, authors affiliated with Pfizer (United Kingdom) have published 5.4k papers, which have received a total of 208.0k indexed citations. Scholars at this organization have produced 1.2k papers in Molecular Biology, 573 papers in Organic Chemistry and 512 papers in Epidemiology on the topics of Analytical Chemistry and Chromatography (302 papers), Computational Drug Discovery Methods (202 papers) and Pharmacogenetics and Drug Metabolism (185 papers). Their work is cited by papers focused on Molecular Biology (54.2k citations), Organic Chemistry (24.7k citations) and Epidemiology (19.5k citations). Authors at Pfizer (United Kingdom) collaborate with scholars in United Kingdom, United States and Germany and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Pfizer (United Kingdom)'s most productive authors include Dennis A. Smith, William Jones, John P. Overington, H. Van De Waterbeemd, Andrew L. Hopkins, Tomislav Friščić, Bissan Al‐Lazikani, Don K. Walker, Christopher A. Hitchcock and Eric Gifford.

In The Last Decade

Fields of papers published by authors at Pfizer (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pfizer (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pfizer (United Kingdom) at the time of their publication.

Countries citing scholars working at Pfizer (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pfizer (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pfizer (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfizer (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Desert Research Institute Breakdown of academic impact, for scholars at Marine Scotland Breakdown of academic impact, for scholars at AlbaNova Breakdown of academic impact, for scholars at Westmead Institute Breakdown of academic impact, for scholars at Chimie ParisTech Breakdown of academic impact, for scholars at VA Boston Healthcare System Breakdown of academic impact, for scholars at Abbott (United States) Breakdown of academic impact, for scholars at AstraZeneca (Sweden)
Rankless by CCL
2025